A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis
Not yet recruitingNCT06725017
Guangzhou Zhiyi Biotechnology Co., Ltd.Ulcerative Colitis (UC)
Start: 2025-07-01End: 2027-08-01Target: 60Updated: 2024-12-16